Cipla stock faces Pune licence cancellation after FDA order

Published on 10/05/2026 at 16:08 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cipla stock was at INR 1,335.50 on October 5, 2026, as a Pune licence dispute tested its compliance profile. Q1 FY27 revenue rose 3.5 percent, but profit fell 39.2 percent.

Cipla, INE059A01026, Illustration mit AI erstellt.

Cipla stock (ISIN INE059A01026) was last at INR 1,335.50 on the NSE on October 5, 2026, down 0.63 percent from the previous close. The immediate company issue is a Maharashtra FDA order cancelling the sale and distribution licence of Cipla's Wadki warehouse in Pune effective October 1, 2026.

Pune order raises compliance pressure

As CNBC TV18 reported on October 2, 2026, the regulator linked the action to alleged violations involving Reactin Plus packaging, storage and record keeping. Cipla said the decision was disappointing, maintained that the facility follows distribution and digital record keeping protocols, and said it was reviewing the order.

The order followed a revised show cause notice issued on September 4, a company response on September 11 and a personal hearing on September 21, according to CNBC TV18. That sequence makes the dispute more than a preliminary inspection issue, although the action concerns one distribution facility rather than Cipla's full manufacturing network.

Profit pressure contrasts with revenue growth

Cipla's Q1 FY27 product revenue reached INR 70.8 billion, up 3.5 percent from INR 68.4 billion in Q1 FY26, while consolidated net profit dropped 39.2 percent year over year to INR 7.9 billion from INR 13.0 billion, according to Sahi on October 5, 2026. The same report put the quarter's profit 42.3 percent above Q4 FY26, when consolidated net profit was INR 5.5 billion.

The earnings mix gives the regulatory story a useful counterweight. Revenue continued to expand, but the sharper profit decline shows why execution and cost control matter alongside Cipla's headline sales growth.

Stock remains below yearly high

Cipla's October 5, 2026, NSE range was INR 1,165.70 to INR 1,673.00, leaving the last price 20.2 percent below the 52-week high. Market capitalization stood at INR 1.1 trillion and volume reached 1,084,041 shares on the same date.

The exchange calendar lists Cipla's Q2 FY27 financial results for October 27, 2026. That upcoming report will provide the next quantified test of whether revenue growth can translate into improved earnings after the Q1 decline.

Cipla stock carries a dated market checkpoint

At INR 1,335.50 on the NSE at 3:15 p.m. IST on October 5, 2026, Cipla stock was 0.63 percent below its previous close of INR 1,344.00. The price sat within the session range of INR 1,321.00 to INR 1,337.70, keeping the regulatory order and the October results date as the clearest company-specific checkpoints.